Drug intelligence / Profile preview

Bawei Shenqi Pill

Development stage: Phase 3
Lead developer: Shanghai University of Traditional Chinese Medicine
Administration: Oral

Overview

Bawei Shenqi Pill is a traditional Chinese medicine formula originating from the "Synopsis of the Golden Chamber" (Jin Gui Yao Lue) written by Zhang Zhongjing almost 2000 years ago. It consists of eight herbal ingredients: 1. Radix Rehmanniae praeparata (Shu Di Huang) 2. Fructus Corni (Shan Zhu Yu) 3. Rhizoma Dioscoreae (Shan Yao) 4. Poria (Fu Ling) 5. Cortex Moutan (Mu Dan Pi) 6. Rhizoma Alismatis (Ze Xie) 7. Radix Aconiti Lateralis praeparata (Pao Fu Zi) 8. Cortex Cinnamomi (Rou Gui) According to Traditional Chinese Medicine principles, the formula primarily functions to tonify and warm Kidney Yang, nourish both Yin and Yang, and boost life energy (Qi) that originates in the Kidney.

Brand names: JIUZHITANG Guifu Dihuang WanDITAI Guifu Dihuang Pill
Other names: Jin Gui Shen Qi WanKidney Qi PillEight-Ingredient Kidney Qi PillJin Kui Shen Qi WanBa Wei Shen Qi WanBa Wei Di Huang WanGui Fu Di Huang WanFu Gui Di Huang WanJingui Shenqi PillJingui Shenqi WanGuifu Dihuang WanCui Shi Ba Wei WanEight Ingredient Rehmannia PillRehmannia Eight Formula

Targets

JUN (Transcription factor Jun)VEGFA (Vascular endothelial growth factor A)JNK (Mitogen-activated protein kinase kinase kinase family)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)MYC (MYC proto-oncogene protein)IL-6 (Interleukin 6)

Beyond the preview

Go deeper on Bawei Shenqi Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bawei Shenqi Pill.

Explore the full profile